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Abstract 
Background: Malaria in pregnancy is common in sub‑Saharan Africa where it contributes to perinatal morbidity and 
mortality. Use of insecticide‑treated bed nets and intermittent preventive therapy with sulfadoxine–pyrimethamine 
during pregnancy are effective but underutilized interventions to prevent infection. Factors associated with bed net 
ownership and usage, and use of prophylaxis among recently pregnant women in Cameroon were investigated.
Methods: National data from the 2011 Cameroon Demographic Health Survey was used to identify women with a 
pregnancy within the previous 5 years. Logistic regression models were created to assess for independent predictors 
of reported bed net ownership, bed net usage, and the use of malaria prophylaxis medications during pregnancy.
Results: Nearly one in two women surveyed had a recent pregnancy (n = 7647). In this group, bed net ownership 
and usage rates were low (33.7 and 16.9%, respectively); 61.6% used medication for malaria prophylaxis during preg‑
nancy. Bed net ownership and usage were associated with maternal literacy (aOR 1.4 for net usage, 95% CI 1.1–1.8) 
and the presence of children under age 5 in the home (aOR 2.3 for net usage, 95% CI 1.6–3.3). The use of malaria 
prophylaxis medication was associated with measures of healthcare access (aOR 17.8, 95% CI 13–24.5 for ≥4 antenatal 
care visits), higher maternal education (aOR 1.5, 95% CI 1.1–2.1) and maternal literacy (aOR 1.4, 95% CI 1.1–1.7).
Conclusions: Women in Cameroon and their antenatal providers missed many opportunities to prevent malaria in 
pregnancy. Efforts toward ensuring universal bed net provision, consistent antenatal care and the education of girls 
are likely to improve birth outcomes attributable to malaria infection.
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Background
There were 214 million cases of malaria reported world-
wide in 2015 and an estimated 438,000 associated deaths 
[1]. Pregnant women are particularly susceptible to 
malaria and the highest infection rates worldwide are 
in sub-Saharan Africa [2–4]. Prevention of malaria in 
pregnancy can reduce the risk of severe maternal anae-
mia by 38%, low infant birthweight by 43% and perina-
tal mortality by 27% [5]. Prevention is important since 
many pregnant women with malaria are asymptomatic. 
Currently available preventive interventions include 
insecticide-treated bed nets (ITNs) and malaria prophy-
laxis regimens (intermittent preventive therapy or IPT). 
The World Health Organization (WHO) cites universal 
access to malaria prevention tools as one of the pillars of 
the pathway toward malaria elimination [6].
Insecticide-treated bed nets are effective and one of 
few malaria prevention options that are recommended 
during the first trimester of pregnancy [7–12]. Cur-
rent ITN ownership rates range from 3 to 80% and 
rates of ITN usage in pregnant women in sub-Saharan 
Africa are low (17% in one recent review) [1, 13, 14]. 
ITN ownership and usage have been associated with 
higher levels of education, income and urban resi-
dence [13]. There was a nationwide bed net campaign 
in Cameroon in 2011; 9 million nets were distributed 
at facility and community levels. Malaria prophylaxis 
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with intermittent sulfadoxine–pyrimethamine (IPT-
SP) during the 2nd and 3rd trimesters of pregnancy 
has been recommended by WHO in areas of moder-
ate to high malaria transmission since 2004. IPT-SP 
is recommended for prophylaxis during pregnancy in 
Cameroon and has been available at no cost since 2006 
[15]. SP has efficacy for 4–6  weeks after a single dose 
and improved outcomes are seen with repeated dosing 
[16–18]. Based on this data and concerns about emerg-
ing resistance, WHO recommends provision of at least 
three doses of SP in ANC clinic; Cameroon transi-
tioned from a 2-dose to a 3-dose recommendation for 
IPT-SP in 2012 [19–21]. In order to improve malaria 
prevention in the vulnerable population of pregnant 
women, we sought a better understanding of the usage 
of available interventions. Data from a large national 
survey was used to identify factors associated with 
access to and use of malaria prophylaxis tools among 




Surveys were collected in Cameroon between Janu-
ary and August of 2011 as part of the cross-sectional 
National Demographic Health Survey (DHS) [22]. 
These recurring household level surveys have been 
carried out using previously described methods and 
survey data was weighted to make it nationally rep-
resentative [22–24]. Data was collected from 15,426 
eligible women who were interviewed using two-
stage stratified sampling techniques. This study cap-
tures responses from the subset of 7647 women who 
reported a birth in the previous 5  years. Surveys 
included detailed questions about socio-demograph-
ics, pregnancy history, access to antenatal care ser-
vices, site of delivery and the use of interventions to 
prevent malaria during the most recent pregnancy. 
Blood was collected from a subset of women for rapid 
HIV testing. DHS data has been cleaned, is devoid of 
personal identifiers and datasets are publicly available 
to researchers upon request.
Definitions
Outcome variables
1. Bed net ownership. This DHS query was “Do you 
have a bed net at your house that can be used for 
sleeping?” The ownership of any type of bed net was 
captured.
2. Bed net usage. Among those who owned a bed net, 
women were asked the standard Roll Back Malaria 
Initiative indicator “Did you sleep under a bed net on 
the night prior to the survey?”
3. Usage of any malaria prophylaxis medication during 
the most recent pregnancy (not including the current 
pregnancy).
4. Number of doses of prophylactic sulfadoxine–
pyrimethamine (SP) received (during the most recent 
pregnancy). This was categorized into 3 separate 
dichotomous variables: 0 vs 1+ doses; 0–1 vs 2+ 
doses; 0–2 vs 3+ doses.
Independent variables
Sociodemographics included age, partner’s age, educa-
tion, literacy (ability to read a written phrase in the lan-
guage of choice), partner’s education, marital status, 
polygamy, religion, urban/rural residence (rural defined 
as a population density  <20,000 people), region of the 
country (10 official regions plus separate categories for 
the two largest urban areas; Douala and Yaoundé i.e., 
12 regional categories), ownership of a means of trans-
portation (bicycle, motorcycle or car), parity, number of 
children  <5  years of age in the household, HIV status, 
current contraception use according to the WHO cat-
egories (modern = sterilization, pill, intrauterine device, 
injectable, implant, condoms or lactational amenorrhea; 
traditional  =  rhythm method or withdrawal), employ-
ment (in the past 12 months) and wealth. Wealth was cat-
egorized by DHS into quintiles (numbered 1–5 in order 
of increasing wealth) based on a composite measure of 
the household cumulative living standard [24]. Measures 
of health care utilization and access included visiting a 
health facility in the past 12  months, type of antenatal 
care provider seen at least once (physician, nurse or aux-
iliary nurse), location of antenatal care (hospital, health 
centre or home), number of total antenatal clinic visits, 
timing (trimester) of the first antenatal clinic visit and the 
location of delivery.
Statistical analysis
Descriptive statistics were used for women surveyed 
who reported a pregnancy in the previous 5 years. Logis-
tic regression models were fit to evaluate associations 
between independent variables and the six dichotomous 
outcomes of interest (bed net ownership, bed net usage, 
use of any medication for malaria prophylaxis, and 3 sep-
arate SP dosing measures (at least 1 vs >1 dose, at least 2 
vs >2 doses, at least 3 vs >3 doses). Separate univariate 
(UV) and multi-variable (MV) models were fit for each 
outcome. All variables in Table 1 were considered for the 
MV models and variables were selected based on sta-
tistical significance in the univariate models (p  <  0.05), 
review of existing literature and collinearity considera-
tions. The same set of independent variables was used in 
all MV models. Sensitivity analyses were performed by 
fitting various MV models with and without the variables 
Page 3 of 10Dionne‑Odom et al. Malar J  (2017) 16:132 




 Age‑median (IQR) 26.6 (22.0–32.4)
 Age of husband/partner‑median (IQR) (n = 6417)a 35.9 (29.7–43.4)
 Relationship status
  Married 5248 (68.6)
  Living with partner 1286 (16.8)
  Widowed, divorced, or separated 482 (6.3)
  Never in union 631 (8.3)
 Polygamy (n = 7639)
  Monogamous 4603 (60.3)
  Polygamous 1605 (21)
  Don’t know 317 (4.2)
  Not married 1114 (14.6)
 Education level
  None 2020 (26.4)
  Primary school 2910 (38.1)
  Secondary school or higher 2717 (35.5)
 Education level of partner (n = 7281)
  None 1508 (20.7)
  Primary school 2238 (30.7)
  Secondary school or higher 2903 (39.9)
  Never married 632 (8.7)
 Literacy (n = 7477)
  Literate 3790 (50.7)
  Illiterate 3687 (49.3)
 Wealth quintile
  1st (poorest) 1606 (21)
  2nd 1585 (20.7)
  3rd 1542 (20.2)
  4th 1540 (20.1)
  5th (wealthiest) 1374 (18)
 Religion (n = 7555)
  Christian (catholic or protestant) 5015 (66.4)
  Muslim 1890 (25)
  Other/none 650 (8.6)
 Location of home
  Urban 3472 (45.4)
  Rural 4175 (54.6)
 Own a method of transportation (bicycle, motorcycle or car) 
(n = 7635)
  Yes 3066 (40.2)
  No 4569 (59.8)
 HIV status (n = 3544)
  Positive 177 (5)
  Negative 3367 (95)
 Currently pregnant
  Yes 1061 (13.9)




  1–2 3101 (40.5)
  3–4 2117 (27.7)
  5+ 2429 (31.8)
 Number of children <5 in the household
  0 472 (6.2)
  1–2 4941 (64.6)
  3+ 2234 (29.2)
 Current contraceptive use
  Modern method 1161 (15.2)
  Traditional method 665 (8.7)
  None 5821 (76.1)
 Employment in the past 12 months (n = 7645)
  Yes 5657 (74)
  No 1988 (26)
Antenatal care
 Visited a health facility in the past 12 months (n = 7637)
  Yes 5058 (66.2)
  No 2579 (33.8)
 Antenatal care provider (at least once) (n = 7582)
  Physician 1714 (22.6)
  Nurse 4254 (56.1)
  Auxiliary nurse 507 (6.7)
  None 1107 (14.6)
 Antenatal care location (n = 7489)
  Hospital 2975 (39.7)
  Health centre 3366 (44.9)
  Home 41 (0.6)
  No ANC visits 1107 (14.8)
 Timing of initial ANC visit (n = 7609)
  First trimester 2620 (34.4)
  Second trimester 3489 (45.9)
  Third trimester 393 (5.2)
  No ANC visits 1107 (14.5)
 Number of ANC visits during pregnancy (n = 7565)
  0 1107 (14.6)
  1–2 580 (7.7)
  3 1122 (14.8)
  4+ 4756 (62.9)
Delivery location (n = 7580)
 Health facility 4952 (65.3)
 Home 2628 (34.7)
Malaria prophylaxis in pregnancy
 Have a bed net at home for sleeping (n = 7644)
  Yes 2580 (33.7)
  No 5064 (66.3)
 Slept under a bed net on the night prior to the survey
  Yes 1291 (16.9)
  No 6357 (83.1)
 Took any malaria prophylaxis medication (n = 7608)
  Yes 4686 (61.6)
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that showed collinearity. Since region of residence and 
urban/rural residence were highly collinear with the 
wealth variable, they were excluded from the MV mod-
els. The timing of the initial ANC visit, provider type and 
facility type were also excluded from MV models due to 
collinearity with one another. Missing data is presented 
in the tables but data points were generally complete. UV 
and MV odds ratios with 95% confidence intervals are 
presented in the tables and UV and MV odds ratios are 
shown in a figure. All analyses were performed with SAS 
9.4 (Cary, NC) and results were adjusted for weighting, 
clustering and stratification using the SAS/STAT® “SUR-
VEY” procedures.
Results
The 2011 DHS survey captured 7647 women with a 
reported pregnancy in the previous 5 years. The median 
age of this group was 27  years, the literacy rate was 
50.7% and 1/3 had attended secondary school or higher 
(Table  1). There was a representation of women from 
across the country in urban and rural settings, and most 
women were married (68.6%), Christian (66.4%) and 
employed (74%). Access to ANC care was good with 
85.4% reporting at least one visit, 62.9% reporting at least 
four visits and 45.9% had their initial visit during the sec-
ond trimester. Nearly 60% had a parity of 3 or more.
Only 33.7% of women reported having a bed net 
at home, and 16.9% had slept under a net on the night 
prior to the survey. Of the 3303 women who took SP, 
38.2% received 1 dose, 32.5% received 2 doses and 29.3% 
received 3 or more doses (Table 1). The subset of women 
who were pregnant at the time of survey (n = 1061) had 
similar findings, with 32% bed net ownership and 15% 
bed net usage. Nearly 2 in 3 women used medication for 
malaria prophylaxis during their most recent pregnancy 
and in this group, most took SP (67.5%).
Bed net ownership
Table  2 shows the results of the multivariable analysis. 
In terms of bed net ownership, the univariate analysis 
showed an association with maternal primary school 
education (compared to no education), owning a method 
of transportation, the presence of children under age 5 in 
the home and measures of improved access to healthcare. 
Women who were not married were less likely to own a 
bed net. In the adjusted models, bed net ownership was 
associated with the presence of children under 5 in the 
home (aOR 2.3, 95% CI 1.7–3.1 for 3 or more children), 
more frequent ANC visits (aOR 1.6, 95% CI 1.3–1.9 for 
4 or more visits), maternal literacy (aOR 1.2, 95% CI 
1.02–1.5) and ownership of transportation (aOR 1.2, 95% 
CI 1.1–1.4). There was very little regional variation in bed 
net ownership.
Bed net usage
Factors in the unadjusted models associated with bed net 
usage (among those who owned a bed net) included older 
maternal age, higher educational level (woman and part-
ner), literacy, higher wealth quintile, use of contraception 
and having children under age 5 in the home. Decreased 
bed net usage was associated with polygamy and owning 
a means of transportation. Regional variation was noted 
in bed net usage: women in more populated regions 
(such as urban Douala and Adamaoua) had higher usage 
than women in the more sparsely populated Extreme 
North region. After multivariable adjustment, usage was 
associated with a higher number of children under age 5 
in the home (aOR 2, CI 1.3–3 for 3+ children), number 
of ANC visits (aOR 2, CI 1.4–2.8 for 1+ visit), maternal 
primary school education (aOR 1.5, CI 1.1–2.1), mater-
nal literacy (aOR 1.4, CI 1.1–1.8) and having a facility 
delivery (aOR 1.3, CI 1.1–1.7). Women who were wid-
owed, divorced or separated were less likely to use a bed 
net compared to women who were married (aOR 0.6, CI 
0.4–0.8). Wealth quintile and maternal age did not pre-
dict any of the outcomes in the adjusted models. When 
the model was run with urban/rural residence replacing 
wealth index (two collinear variables), it was not associ-
ated with the outcome.
Table 1 continued
Characteristic N (%)
  No 2922 (38.4)
 Malaria prophylaxis medication received (n = 7742)b
  Sulfadoxine–pyrimethamine (SP) 3321 (42.9)
  Quinine 691 (8.9)
  Artemether–lumefantrine 285 (3.7)
  Amodiaquine 258 (3.3)
  Chloroquine 123 (1.6)
  Other medication 242 (3.1)
  None/don’t know 2822 (36.5)
 Number of SP doses received (n = 7492)
  0 4189 (55.9)
  1 1262 (16.8)
  2 1072 (14.3)
  3+ 969 (12.9)
 Source of malaria prophylaxis medication (n = 3242)
  ANC clinic 3170 (97.8)
  Other medical clinic 32 (1)
  Other source 40 (1.2)
Data adjusted for weighting, clustering and stratification
a  Numbers in parenthesis show the denominator for each variable due to 
missing data
b  More than one response allowed
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Table 2 Multivariable logistic regression models to  determine factors associated with  use of  malaria prophylaxis tools 
in pregnancy
Characteristic Bed net ownership (n = 7235) Bed net usage (n = 7239) Use of any prophylaxis medication 
(n = 7226)
Adjusted OR (95% CI) Adjusted OR (95% CI) Adjusted OR (95% CI)
Age
 Per 10 years 1 (0.9–1.1) 1.1 (0.9–1.2) 1.1 (1–1.2)
Education
 None Ref Ref Ref
 Primary 1.2 (1–1.4) 1.5 (1.1–2.1) 1.3 (1.05–1.6)
 Secondary 0.9 (0.7–1.2) 1.1 (0.7–1.8) 1.5 (1.1–2.1)
Literacy
 No Ref Ref Ref
 Yes 1.2 (1.02–1.5) 1.4 (1.1–1.8) 1.4 (1.1–1.7)
Wealth quintile (lowest to highest)
 1st Ref Ref Ref
 2nd 1 (0.8–1.2) 1 (0.7–1.3) 1.1 (0.9–1.4)
 3rd 0.9 (0.8–1.2) 0.9 (0.7–1.3) 1.1 (0.8–1.3)
 4th 1 (0.7–1.2) 0.9 (0.6–1.2) 1.2 (1–1.6)
 5th 1 (0.8–1.3) 1 (0.7–1.4) 1 (0.7–1.3)
Religion
 Muslim Ref Ref Ref
 Christian 0.9 (0.8–1.1) 1.2 (1–1.6) 0.8 (0.6–0.95)
 Other/none 0.8 (0.7–1.1) 0.9 (0.7–1.4) 0.7 (0.5–0.98)
Parity
 1–2 Ref Ref Ref
 3–4 1 (0.8–1.2) 1 (0.9–1.3) 1.2 (1.02–1.4)
 5+ 1 (0.8–1.3) 1 (0.8–1.3) 1 (0.8–1.2)
# Children under five at home
 0 Ref Ref Ref
 1–2 1.9 (1.5–2.5) 2.3 (1.6–3.3) 1.1 (0.8–1.4)
 3+ 2.3 (1.7–3.1) 2 (1.3–3) 1.1 (0.8–1.4)
Relationship status
 Married Ref Ref Ref
 Living with partner 0.8 (0.7–1) 0.9 (0.7–1.1) 0.8 (0.7–0.97)
 Widowed, divorced or separated 0.8 (0.6–1) 0.6 (0.4–0.8) 0.8 (0.6–1.1)
 Never in union 0.8 (0.7–1) 0.9 (0.7–1.1) 0.7 (0.6–0.9)
Transportation
 No Ref Ref Ref
 Yes 1.2 (1.1–1.4) 1 (0.8–1.1) 1 (0.9–1.2)
Current contraception
 None Ref Ref Ref
 Traditional 1.2 (1.01–1.5) 1.2 (0.9–1.5) 1.1 (0.9–1.4)
 Modern 1 (0.8–1.2) 1 (0.8–1.2) 1 (0.9–1.2)
Visited health facility in past year
 No Ref Ref Ref
 Yes 1.1 (1–1.3) 1.1 (0.9–1.3) 1.3 (1.1–1.5)
Total ANC visits
 0 Ref Ref Ref
 1–2 1.4 (1.03–1.8) 2 (1.4–2.8) 10.3 (7.2–14.6)
 3 1.3 (1.1–1.7) 1.8 (1.2–2.6) 14.6 (10.6–20.2)
 4+ 1.6 (1.3–1.9) 2 (1.4–2.8) 17.8 (13–24.5)
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Malaria prophylaxis medication use
In the univariate models for usage of any malaria proph-
ylaxis medication during the most recent pregnancy, 
an association was seen with literacy, education, higher 
wealth index, urban residence, HIV-positive status, num-
ber of ANC visits and facility delivery. Polygamy, having 
an older partner, parity >5, ANC care at a health centre 
(compared to a hospital clinic) and later presentation for 
ANC care were negatively associated (data not shown). 
In the adjusted models, an independent association was 
seen for more ANC visits (aOR 17.8, 95% CI 13–24.5 for 
4+ visits), maternal education (aOR 1.5, 95% CI 1.1–2.1 
for secondary compared to none), maternal literacy (aOR 
1.4, 95% CI 1.1–1.7), having visited a health facility in the 
past year (aOR 1.3, 95% CI 1.1–1.5) and higher parity 
(aOR 1.2, 95% CI 1.02–1.4 for 3–4 compared to 1–2).
Factors associated with the use of higher doses of SP 
(three separate outcomes) are displayed in Table  3. The 
factor most strongly associated with increased SP dosing 
was a higher number of ANC visits (aOR 25.4, CI 12.3–
52.5 for the association of 4+ visits with 3+ SP doses). 
Maternal primary school education and having visited a 
health facility in the past year were associated with the 
receipt of at least one dose of SP and literacy was associ-
ated with the receipt of 1–2 doses of SP. Wealth quintile 
was not associated with the number of SP doses received. 
Parity greater than 2 had a negative association with 
receiving at least 2 doses of SP and a relationship status 
of “living with partner” or “never in union” was negatively 
associated with receipt of higher doses of SP compared 
to married women (aOR 0.6, 95% CI 0.5–0.8 for never in 
union).
Figure 1 shows the differences in odds ratios and 95% 
CIs between the UV and MV models by outcome. It 
highlights the importance of the MV model in adjusting 
for covariates and the primacy of ANC care in terms of 
the medication-related outcomes.
Discussion
This study of more than 7500 women with a recent preg-
nancy in Cameroon highlights the poor utilization of 
available tools for malaria prevention despite persistent 
and endemic disease rates. This finding is consistent 
with prior studies and particular characteristics were 
identified to be associated with intervention use at the 
individual, provider, system and community levels. This 
information is relevant to inform future prevention 
efforts.
Bed net ownership
Only one in three women with a recent pregnancy owned 
a bed net. There was a wide range of bed net ownership 
(3–80%) documented by Singh et  al. among pregnant 
women in sub-Saharan Africa [13]. The strongest predic-
tors of net ownership in our study were maternal literacy, 
the number of young children in the house, and antenatal 
care. The association with maternal education is consist-
ently seen, but the current analysis did not confirm the 
previous association with wealth index, parity or urban 
residence [13]. Also, bed net ownership rates were simi-
lar in all regions of the country. These positive findings 
point to equity in net ownership which may be attributed 
to public health campaigns that aim to disseminate bed 
nets widely at no cost [25]. The strong association with 
the presence of young children at home is likely due to 
patterns of prioritized net distribution for these house-
holds in the past [13, 23].
Bed net usage
In this study, bed net usage rates were low at 16.9%. The 
rate of net usage during pregnancy was similarly low in 
Nigeria (26%) and 17% in sub-Saharan Africa overall [13, 
14]. The clear discrepancy between net ownership and 
usage in pregnancy has been documented and some of 
the cited explanations include: discomfort, torn nets and 
a perception that nets are unnecessary [13, 26]. Maternal 
education, literacy, wealth, urban residence and older age 
have been variably associated with bed net usage in ear-
lier studies but only maternal literacy and education were 
associated in this adjusted model [13, 27]. One explana-
tion for this difference may be that public health mes-
saging in support of bed nets in Cameroon has reached 
a broader population, including younger women, those 
with a lower socioeconomic status or women in rural 
Multivariable logistic regression models were adjusted for weighting, clustering and stratification. All variables in the table were included in the model
Ref referent value, SP sulfadoxine–pyrimethamine, OR odds ratio
Table 2 continued
Characteristic Bed net ownership (n = 7235) Bed net usage (n = 7239) Use of any prophylaxis medication 
(n = 7226)
Adjusted OR (95% CI) Adjusted OR (95% CI) Adjusted OR (95% CI)
Delivery location
 Home Ref Ref Ref
 Facility 1 (0.8–1.2) 1.3 (1.1–1.7) 1 (0.8–1.2)
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Table 3 Multivariable logistic regression models to  determine factors associated with  the use of  higher doses of  sulf-
adoxine–pyrimethamine (SP) for malaria prophylaxis in pregnancy (n = 7121)
Characteristic 0 vs 1+ doses of SP 0–1 vs 2+ doses of SP 0–2 vs 3+ doses of SP
Adjusted OR (95% CI) Adjusted OR (95% CI) Adjusted OR (95% CI)
Age
 Per 10 years 1 (0.9–1.2) 1.1 (0.9–1.2) 1.1 (0.9–1.3)
Education
 None Ref Ref Ref
 Primary 1.3 (1.04–1.7) 1.1 (0.9–1.3) 1.1 (0.8–1.5)
 Secondary 1.3 (0.9–1.8) 1 (0.8–1.3) 1.4 (0.9–2)
Literacy
 No Ref Ref Ref
 Yes 1.3 (1.04–1.5) 1.3 (1.1–1.6) 1 (0.7–1.3)
Wealth quintile (lowest to highest)
 1st Ref Ref Ref
 2nd 1.1 (0.9–1.4) 1.1 (0.9–1.5) 0.8 (0.6–1.1)
 3rd 1.1 (0.8–1.3) 1.2 (0.9–1.5) 0.9 (0.7–1.3)
 4th 1 (0.8–1.4) 1.1 (0.8–1.5) 1 (0.7–1.4)
 5th 0.8 (0.6–1.1) 1.2 (0.9–1.5) 1.2 (0.8–1.7)
Religion
 Muslim Ref Ref Ref
 Christian 0.8 (0.6–1.1) 0.9 (0.7–1.1) 0.9 (0.7–1.2)
 Other/none 0.9 (0.7–1.3) 0.8 (0.6–1.1) 0.9 (0.6–1.4)
Parity
 1–2 Ref Ref Ref
 3–4 0.9 (0.8–1.1) 0.8 (0.7–.98) 0.9 (0.7–1.1)
 5+ 0.8 (0.7–1) 0.7 (0.6–0.9) 0.8 (0.6–1.1)
# Children under five at home
 0 Ref Ref Ref
 1–2 1 (0.8–1.3) 0.9 (0.7–1.2) 0.8 (0.6–1.1)
 3+ 1.1 (0.9–1.5) 1 (0.7–1.3) 0.9 (0.6–1.2)
Relationship status
 Married Ref Ref Ref
 Living with partner 0.6 (0.5–0.7) 0.7 (0.6–0.8) 0.7 (0.6–0.9)
 Widowed, divorced or separated 0.8 (0.6–0.96) 0.9 (0.7–1.1) 1 (0.8–1.4)
 Never in union 0.7 (0.5–0.8) 0.6 (0.5–0.8) 0.7 (0.5–0.9)
Transportation
 No Ref Ref Ref
 Yes 1 (0.8–1.1) 1 (0.9–1.2) 1 (0.9–1.2)
Current contraception
 None Ref Ref Ref
 Traditional 1.2 (0.9–1.4) 1 (0.8–1.2) 1.2 (0.9–1.5)
 Modern 1 (0.8–1.2) 1 (0.8–1.2) 1 (0.7–1.3)
Visited health facility in past year
 No Ref Ref Ref
 Yes 1.2 (1.05–1.4) 1 (0.8–1.1) 0.9 (0.7–1.1)
Number of antenatal clinic visits
 0 Ref Ref Ref
 1–2 19.4 (11–34.4) 10.2 (5.3–19.5) 3.5 (1.4–8.5)
 3 30.5 (17.8–52.4) 24.8 (12.9–47.8) 18.9 (8.8–40.3)
 4+ 37.4 (22.1–63.2) 33.1 (17.8–61.8) 25.4 (12.3–52.5)
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Multivariable logistic regression models adjusted for weighting, clustering and stratification. All of the variables in the table were included in the model
Ref referent level, SP sulfadoxine–pyrimethamine, OR odds ratio
Table 3 continued
Characteristic 0 vs 1+ doses of SP 0–1 vs 2+ doses of SP 0–2 vs 3+ doses of SP
Adjusted OR (95% CI) Adjusted OR (95% CI) Adjusted OR (95% CI)
Delivery location
 Home Ref Ref Ref
 Facility 1 (0.9–1.3) 1 (0.8–1.2) 0.9 (0.7–1.2)
Fig. 1 Odds ratios from univariate (orange) and multivariable (blue) logistic regression models (adjusted for weighting, clustering and stratification) 
by outcome
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areas but the major message is that usage rates are too 
low. This study, like others, supports the need for long-
term investment in the education of girls.
Use of prophylaxis medication
Only 6 in 10 women were prescribed medication for 
malaria prophylaxis during pregnancy and about one in 
four (27.2%) received the recommended 2 or more doses 
of SP. This is consistent with the recent World Malaria 
Report, where 57% of pregnant women in sub-Saha-
ran Africa received SP, 43% received 2 doses and 17% 
received 3 or more doses [21]. Nonetheless, prophylaxis 
rates have improved significantly in sub-Saharan Africa 
(SP coverage was 19% in 2007) [14]. The strong associa-
tion between the number of ANC visits and use of pro-
phylactic medication is expected since these medications 
are most often administered from ANC clinic. There is an 
obvious clinical benefit to 2 or 3 doses of SP compared 
to single dose and longer time (>10  weeks) between 
doses has been associated with suboptimal outcomes 
[28]. Wealth was associated with access to and use of 
malaria prophylaxis medications in prior studies but was 
not seen in this study [21, 29]. Access to malaria prophy-
laxis among pregnant women may have become more 
equitable in Cameroon due to affordable essential drug 
schemes which lower costs for all.
Strengths and weaknesses
The strengths of this study include its size and the survey 
methods involving weighted data from national house-
hold surveys designed to be representative. The compre-
hensive data collection allowed for exploration of several 
individual level factors as well as measures of healthcare 
access. Limitations of this study include the single coun-
try design, use of data from 2011 and self-reported meas-
ures. A few additional limitations inherent to the survey 
methods include recall bias (pregnancy up to 5  years 
before the survey) and social desirability bias (the desire 
to give the “correct” answer to the person administering 
the survey). Analysis based on region, ANC provider type 
or facility type was not performed because of collinear-
ity. Most of the women queried about bed nets were not 
pregnant at the time of the survey but were of childbear-
ing age with a recent pregnancy and this was used as a 
proxy for the behavior of women during pregnancy. Bed 
net usage was defined by the standard indicator of hav-
ing slept under a net on the night prior to the survey. 
This may not be best indicator of actual usage although 
it is commonly used and it is the outcome for the “Roll 
Back Malaria Initiative”. Pregnancy outcomes related to 
malaria infection were not available. Finally, because of 
multiple comparisons, some of the associations noted 
may have occurred by chance alone.
Conclusions
This study highlights important opportunities to opti-
mize malaria prevention efforts in pregnancy in Cam-
eroon. Insecticide-treated bed nets should be offered 
universally and use encouraged in antenatal clinic. Com-
munity-based bed net distribution should continue since 
households with access to a means of transportation were 
more likely to own a net and women living in more rural 
regions were less likely to sleep under nets. In order to 
reach the 2016 WHO malaria indicator of “the propor-
tion of pregnant women who receive at least 3 or more 
doses of IPT in ANC clinic”, women should be encour-
aged to seek prenatal care early in pregnancy and pro-
viders should recognize every visit as an opportunity to 
discuss, recommend and offer malaria prevention tools. 
Since women with children under 5 years old were more 
likely to have and use a bed net, targeted efforts to edu-
cate primiparous women about malaria prevention in 
pregnancy may be useful. On a broader scale, education 
must remain a national priority in Cameroon given the 
relevance of maternal literacy and level of parental edu-
cation as it impacts the use of malaria prevention tools.
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